Literature DB >> 17616709

Positive cross-regulatory loop ties GATA-3 to estrogen receptor alpha expression in breast cancer.

Jérôme Eeckhoute1, Erika Krasnickas Keeton, Mathieu Lupien, Susan A Krum, Jason S Carroll, Myles Brown.   

Abstract

The transcription factor GATA-3 is required for normal mammary gland development, and its expression is highly correlated with estrogen receptor alpha (ER alpha) in human breast tumors. However, the functional role of GATA-3 in ER alpha-positive breast cancers is yet to be established. Here, we show that GATA-3 is required for estradiol stimulation of cell cycle progression in breast cancer cells. The role of GATA-3 in estradiol signaling requires the direct positive regulation of the expression of the ER alpha gene itself by GATA-3. GATA-3 binds to two cis-regulatory elements located within the ER alpha gene, and this is required for RNA polymerase II recruitment to ER alpha promoters. Reciprocally, ER alpha directly stimulates the transcription of the GATA-3 gene, indicating that these two factors are involved in a positive cross-regulatory loop. Moreover, GATA-3 and ER alpha regulate their own expression in breast cancer cells. Hence, this transcriptional coregulatory mechanism accounts for the robust coexpression of GATA-3 and ER alpha in human breast cancers. In addition, these results highlight the crucial role of GATA-3 for the response of ER alpha-positive breast cancers to estradiol. Moreover, they identify GATA-3 as a critical component of the master cell-type-specific transcriptional network including ER alpha and FoxA1 that dictates the phenotype of hormone-dependent breast cancer.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17616709     DOI: 10.1158/0008-5472.CAN-07-0746

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  178 in total

Review 1.  Intrinsic and Extrinsic Factors Governing the Transcriptional Regulation of ESR1.

Authors:  David K Lung; Rebecca M Reese; Elaine T Alarid
Journal:  Horm Cancer       Date:  2020-06-26       Impact factor: 3.869

2.  Gata-3 negatively regulates the tumor-initiating capacity of mammary luminal progenitor cells and targets the putative tumor suppressor caspase-14.

Authors:  Marie-Liesse Asselin-Labat; Kate D Sutherland; François Vaillant; David E Gyorki; Di Wu; Sheridan Holroyd; Kelsey Breslin; Teresa Ward; Wei Shi; Mary L Bath; Siddhartha Deb; Stephen B Fox; Gordon K Smyth; Geoffrey J Lindeman; Jane E Visvader
Journal:  Mol Cell Biol       Date:  2011-09-19       Impact factor: 4.272

Review 3.  Progesterone receptors, their isoforms and progesterone regulated transcription.

Authors:  Britta M Jacobsen; Kathryn B Horwitz
Journal:  Mol Cell Endocrinol       Date:  2011-09-17       Impact factor: 4.102

4.  Higher levels of GATA3 predict better survival in women with breast cancer.

Authors:  Nam K Yoon; Erin L Maresh; Dejun Shen; Yahya Elshimali; Sophia Apple; Steve Horvath; Vei Mah; Shikha Bose; David Chia; Helena R Chang; Lee Goodglick
Journal:  Hum Pathol       Date:  2010-12       Impact factor: 3.466

5.  Thyroid Hormone Receptor β Inhibits Self-Renewal Capacity of Breast Cancer Stem Cells.

Authors:  Irene López-Mateo; Elvira Alonso-Merino; Cristian Suarez-Cabrera; Jeong Won Park; Sheue-Yann Cheng; Susana Alemany; Jesús M Paramio; Ana Aranda
Journal:  Thyroid       Date:  2019-12-30       Impact factor: 6.568

6.  Loss of ERα and FOXA1 expression in a progression model of luminal type breast cancer: insights from PyMT transgenic mouse model.

Authors:  Kasi McCune; Rutika Mehta; Mangesh A Thorat; Sunil Badve; Harikrishna Nakshatri
Journal:  Oncol Rep       Date:  2010-11       Impact factor: 3.906

7.  FoxA1 translates epigenetic signatures into enhancer-driven lineage-specific transcription.

Authors:  Mathieu Lupien; Jérôme Eeckhoute; Clifford A Meyer; Qianben Wang; Yong Zhang; Wei Li; Jason S Carroll; X Shirley Liu; Myles Brown
Journal:  Cell       Date:  2008-03-21       Impact factor: 41.582

8.  Cell-type selective chromatin remodeling defines the active subset of FOXA1-bound enhancers.

Authors:  Jérôme Eeckhoute; Mathieu Lupien; Clifford A Meyer; Michael P Verzi; Ramesh A Shivdasani; X Shirley Liu; Myles Brown
Journal:  Genome Res       Date:  2009-01-07       Impact factor: 9.043

9.  Expression of FOXO1 is associated with GATA3 and Annexin-1 and predicts disease-free survival in breast cancer.

Authors:  Yanyuan Wu; Yayha Elshimali; Marianna Sarkissyan; Hezla Mohamed; Sheila Clayton; Jaydutt V Vadgama
Journal:  Am J Cancer Res       Date:  2011-11-21       Impact factor: 6.166

10.  Cooperative interaction between retinoic acid receptor-alpha and estrogen receptor in breast cancer.

Authors:  Caryn S Ross-Innes; Rory Stark; Kelly A Holmes; Dominic Schmidt; Christiana Spyrou; Roslin Russell; Charlie E Massie; Sarah L Vowler; Matthew Eldridge; Jason S Carroll
Journal:  Genes Dev       Date:  2010-01-15       Impact factor: 11.361

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.